Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head-to-head trial of methylphenidate (Concerta) vs lisdexamfetamine (Elvanse) in adults with ADHD
2017-000368-14Phase 4Terminated
- Sponsor
- Sahlgrenska University Hospital
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in attention deficit hyperactivity disorder (ADHD) comparing Concerta arm with Elvanse arm (2 arms). Primary endpoint: Primary endpoint at 6 months. Started Mar 2017; status: terminated.
02
Drugs
methylphenidatelisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2017-000368-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000368-14.